Intra-Cellular Therapies, Inc.
ITCI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$75 | -$140 | -$256 | -$284 |
| Dep. & Amort. | -$9 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | -$4 |
| Stock-Based Comp. | $64 | $53 | $43 | $34 |
| Change in WC | -$54 | -$30 | -$58 | -$6 |
| Other Non-Cash | $0 | -$8 | $1 | $0 |
| Operating Cash Flow | -$73 | -$124 | -$270 | -$260 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | $128 | -$281 |
| Inv. Purchases | -$740 | -$415 | -$759 | -$225 |
| Inv. Sales/Matur. | $405 | $521 | $632 | $505 |
| Other Inv. Act. | $0 | $0 | -$128 | $281 |
| Investing Cash Flow | -$335 | $106 | -$128 | $280 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $543 | $18 | $434 | $12 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $24 | $18 | $21 | $12 |
| Financing Cash Flow | $568 | $18 | $455 | $12 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $159 | -$1 | $57 | $32 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $150 | $150 | $94 | $61 |
| End Cash | $309 | $150 | $150 | $94 |
| Free Cash Flow | -$73 | -$124 | -$271 | -$260 |